Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.

por Sorensen, M., Sehested, M., Jensen, P. B.
Publicado 1995

Societal costs of diabetes mellitus in Denmark

por Sortsø, C., Green, A., Jensen, P. B., Emneus, M.
Publicado 2015

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol,...

por Jensen, P. B., Holm, B., Sorensen, M., Christensen, I. J., Sehested, M.
Publicado 1997

Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.

por Jensen, P. B., Christensen, I. J., Sehested, M., Hansen, H. H., Vindeløv, L.
Publicado 1993

Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.

por Sehested, M., Skovsgaard, T., Jensen, P. B., Demant, E. J., Friche, E., Bindslev, N.
Publicado 1990

Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.

por Sorensen, M., Sehested, M., Christensen, I. J., Larsen, J. K., Jensen, P. B.
Publicado 1998

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells

por Invernizzi, F., D'Amato, I., Jensen, P.B., Ravaglia, S., Zeviani, M., Tiranti, V.
Publicado 2012

Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.

por Kreisholt, J., Sorensen, M., Jensen, P. B., Nielsen, B. S., Andersen, C. B., Sehested, M.
Publicado 1998

Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma

por Marquard, L, Gjerdrum, L M, Christensen, Ib J, Jensen, P B, Sehested, M, Ralfkiaer, E
Publicado 2008

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.

por Sehested, M., Jensen, P. B., Skovsgaard, T., Bindslev, N., Demant, E. J., Friche, E., Vindeløv, L.
Publicado 1989

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

por Jensen, P. B., Vindeløv, L., Roed, H., Demant, E. J., Sehested, M., Skovsgaard, T., Hansen, H. H.
Publicado 1989